Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,533.00 ILa | -0.88% |
|
+0.03% | -5.52% |
| 07-09 | Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus | MT |
| 07-09 | Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada | MT |
| Market Cap | 35.11B 0 30.76B 28.56B 26.24B 49.45B 3,388B 50.18B 340B 133B 1,658B 132B 129B 5,726B | P/E 2026 * |
37.2x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 46.27B 0 40.54B 37.64B 34.58B 65.17B 4,465B 66.13B 448B 175B 2,185B 174B 170B 7,547B | EV / Sales 2026 * |
2.78x | EV / Sales 2027 * | 2.53x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | -0.88% | ||
| 1 week | +0.03% | ||
| Current month | -3.09% | ||
| 1 month | +1.64% | ||
| 3 months | -1.29% | ||
| 6 months | -3.94% | ||
| Current year | -5.52% |
| 1 week | 9,396 |  | 9,930 |
| 1 month | 9,396 | | 10,730 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 3,002 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 21,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.88% | +0.03% | - | - | 35.11B | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,037B | |
| +2.00% | +3.49% | +52.22% | +50.20% | 615B | |
| -1.09% | +3.76% | +35.37% | +76.22% | 448B | |
| -0.42% | +0.67% | +30.81% | +21.05% | 326B | |
| -0.16% | +2.74% | +36.02% | +37.33% | 293B | |
| +1.68% | +1.08% | +22.70% | +17.94% | 264B | |
| -1.40% | -3.34% | -24.63% | -42.39% | 216B | |
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | |
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | |
| Average | -0.34% | +1.12% | +26.70% | +47.73% | 395.27B | |
| Weighted average by Cap. | -0.47% | +1.47% | +35.90% | +72.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.64B 0 14.58B 13.53B 12.43B 23.43B 1,605B 23.78B 161B 63.1B 785B 62.45B 61.1B 2,714B | 17.23B 0 15.1B 14.02B 12.88B 24.27B 1,663B 24.63B 167B 65.36B 814B 64.69B 63.29B 2,811B |
| Net income | 1.31B 0 1.15B 1.06B 979M 1.84B 126B 1.87B 12.69B 4.97B 61.81B 4.91B 4.81B 214B | 2.46B 0 2.16B 2B 1.84B 3.47B 238B 3.52B 23.87B 9.34B 116B 9.25B 9.05B 402B |
| Net Debt | 11.16B 0 9.78B 9.08B 8.34B 15.72B 1,077B 15.95B 108B 42.34B 527B 41.9B 41B 1,821B | 8.41B 0 7.37B 6.84B 6.28B 11.84B 811B 12.01B 81.46B 31.88B 397B 31.56B 30.88B 1,371B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | ILA 9,533.00 | -0.88% | 1,061,041 |
| 21/07/26 | ILA 9,618.00 | -0.25% | 1,288,336 |
| 20/07/26 | ILA 9,642.00 | -0.96% | 759,073 |
| 17/07/26 | ILA 9,735.00 | -0.41% | 485,235 |
| 16/07/26 | ILA 9,775.00 | +2.57% | 1,284,861 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
